The Promise of Preventive Cancer Vaccines
Years of unsuccessful attempts at fighting established tumors with vaccines have taught us all that they are only able to truly impact patient survival when used in a preventive setting, as would normally be the case for traditional vaccines against infectious diseases. While true primary cancer pre...
Main Authors: | Pier-Luigi Lollini, Federica Cavallo, Patrizia Nanni, Elena Quaglino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/2/467 |
Similar Items
-
Cancer immunoprevention: from mice to early clinical trials
by: Arianna Palladini, et al.
Published: (2018-06-01) -
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
by: Patrizia Nanni, et al.
Published: (2018-08-01) -
Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
by: Vincent K. Tuohy, et al.
Published: (2016-06-01) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
by: Ayoub NM, et al.
Published: (2019-01-01) -
COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy
by: Karim Hussien El-Shakankery, et al.
Published: (2021-02-01)